Cases & Deals

  • Home
  • Practices
  • King Pharmaceuticals faces Item Development AB in patent interference involving myocardial dysfunction

Share

King Pharmaceuticals faces Item Development AB in patent interference involving myocardial dysfunction

May 2008

Client(s) King Pharmaceuticals Research & Development, Inc.

Jones Day provided representation to King Pharmaceuticals, Inc. in a patent interference against Item Development AB before the U.S. Patent and Trademark Office involving methods for detecting the presence and assessing the severity of myocardial dysfunction.

King Pharmaceuticals Research & Development, Inc. v. Item Development AB, Interference No. 105,620

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.